Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
-

Safety

  • Share Share this page
-

Caduet (amlodipine besylate/atorvastatin calcium) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- July 2009

 

Summary View

 

ADVERSE REACTIONS

The Atorvastatin Component of CADUET/Postintroduction Reports with Atorvastatin
  • hepatic failure
    
-
-
-
-
-